Validation of the Korean Version of the Breakthrough Pain Assessment Tool in Cancer Patients

Jinyoung Shin, Sung Jung Cho, Jungkwon Lee, Youn Seon Choi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Context Breakthrough cancer pain has not been properly evaluated and treated because there are relatively few available measurements. The Breakthrough Pain Assessment Tool (BAT) is currently recognized as a brief, multidimensional, and reliable measurement. Objectives The objective of this study was to validate the Korean version of the BAT (BAT-K) in adult cancer patients. Methods We conducted a forward-backward translation and cross-cultural equivalence test. The psychometric properties with 120 cancer patients were assessed using factor analysis, reliability, and validity. Results The Korean translation was well accepted by participants. Factor analysis revealed the presence of two underlying factors: frequency/severity and duration/medication efficacy. Cronbach alpha coefficient was 0.743. Severity, distress, and disruption of normal life showed strong reliability. The intraclass correlation for the test-retest reliability was 0.782 (95% confidence interval 0.694–0.854). The BAT-K had significant correlations with the Brief Pain Inventory, Pain Management Index, and Eastern Cooperative Oncology Group performance status (all P values < 0.05). Conclusion The BAT-K is a valid and reliable measurement of breakthrough cancer pain in Korean cancer patients.

Original languageEnglish
Pages (from-to)361-367
Number of pages7
JournalJournal of Pain and Symptom Management
Volume54
Issue number3
DOIs
Publication statusPublished - 2017 Sep 1

Fingerprint

Breakthrough Pain
Pain Measurement
Neoplasms
Reproducibility of Results
Statistical Factor Analysis
Pain Management
Psychometrics
Confidence Intervals
Pain
Equipment and Supplies

Keywords

  • Breakthrough pain
  • neoplasms
  • pain measurement
  • translations
  • validation studies

ASJC Scopus subject areas

  • Nursing(all)
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Validation of the Korean Version of the Breakthrough Pain Assessment Tool in Cancer Patients. / Shin, Jinyoung; Cho, Sung Jung; Lee, Jungkwon; Choi, Youn Seon.

In: Journal of Pain and Symptom Management, Vol. 54, No. 3, 01.09.2017, p. 361-367.

Research output: Contribution to journalArticle

@article{5caee3fce0fa46ceb6d4090a6cc27a14,
title = "Validation of the Korean Version of the Breakthrough Pain Assessment Tool in Cancer Patients",
abstract = "Context Breakthrough cancer pain has not been properly evaluated and treated because there are relatively few available measurements. The Breakthrough Pain Assessment Tool (BAT) is currently recognized as a brief, multidimensional, and reliable measurement. Objectives The objective of this study was to validate the Korean version of the BAT (BAT-K) in adult cancer patients. Methods We conducted a forward-backward translation and cross-cultural equivalence test. The psychometric properties with 120 cancer patients were assessed using factor analysis, reliability, and validity. Results The Korean translation was well accepted by participants. Factor analysis revealed the presence of two underlying factors: frequency/severity and duration/medication efficacy. Cronbach alpha coefficient was 0.743. Severity, distress, and disruption of normal life showed strong reliability. The intraclass correlation for the test-retest reliability was 0.782 (95{\%} confidence interval 0.694–0.854). The BAT-K had significant correlations with the Brief Pain Inventory, Pain Management Index, and Eastern Cooperative Oncology Group performance status (all P values < 0.05). Conclusion The BAT-K is a valid and reliable measurement of breakthrough cancer pain in Korean cancer patients.",
keywords = "Breakthrough pain, neoplasms, pain measurement, translations, validation studies",
author = "Jinyoung Shin and Cho, {Sung Jung} and Jungkwon Lee and Choi, {Youn Seon}",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.jpainsymman.2017.07.011",
language = "English",
volume = "54",
pages = "361--367",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Validation of the Korean Version of the Breakthrough Pain Assessment Tool in Cancer Patients

AU - Shin, Jinyoung

AU - Cho, Sung Jung

AU - Lee, Jungkwon

AU - Choi, Youn Seon

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Context Breakthrough cancer pain has not been properly evaluated and treated because there are relatively few available measurements. The Breakthrough Pain Assessment Tool (BAT) is currently recognized as a brief, multidimensional, and reliable measurement. Objectives The objective of this study was to validate the Korean version of the BAT (BAT-K) in adult cancer patients. Methods We conducted a forward-backward translation and cross-cultural equivalence test. The psychometric properties with 120 cancer patients were assessed using factor analysis, reliability, and validity. Results The Korean translation was well accepted by participants. Factor analysis revealed the presence of two underlying factors: frequency/severity and duration/medication efficacy. Cronbach alpha coefficient was 0.743. Severity, distress, and disruption of normal life showed strong reliability. The intraclass correlation for the test-retest reliability was 0.782 (95% confidence interval 0.694–0.854). The BAT-K had significant correlations with the Brief Pain Inventory, Pain Management Index, and Eastern Cooperative Oncology Group performance status (all P values < 0.05). Conclusion The BAT-K is a valid and reliable measurement of breakthrough cancer pain in Korean cancer patients.

AB - Context Breakthrough cancer pain has not been properly evaluated and treated because there are relatively few available measurements. The Breakthrough Pain Assessment Tool (BAT) is currently recognized as a brief, multidimensional, and reliable measurement. Objectives The objective of this study was to validate the Korean version of the BAT (BAT-K) in adult cancer patients. Methods We conducted a forward-backward translation and cross-cultural equivalence test. The psychometric properties with 120 cancer patients were assessed using factor analysis, reliability, and validity. Results The Korean translation was well accepted by participants. Factor analysis revealed the presence of two underlying factors: frequency/severity and duration/medication efficacy. Cronbach alpha coefficient was 0.743. Severity, distress, and disruption of normal life showed strong reliability. The intraclass correlation for the test-retest reliability was 0.782 (95% confidence interval 0.694–0.854). The BAT-K had significant correlations with the Brief Pain Inventory, Pain Management Index, and Eastern Cooperative Oncology Group performance status (all P values < 0.05). Conclusion The BAT-K is a valid and reliable measurement of breakthrough cancer pain in Korean cancer patients.

KW - Breakthrough pain

KW - neoplasms

KW - pain measurement

KW - translations

KW - validation studies

UR - http://www.scopus.com/inward/record.url?scp=85028340604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028340604&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2017.07.011

DO - 10.1016/j.jpainsymman.2017.07.011

M3 - Article

C2 - 28711749

AN - SCOPUS:85028340604

VL - 54

SP - 361

EP - 367

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 3

ER -